Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

First Prev 92 93 94 95 96 97 98 99 100 101 Next Last
  • Gochin, M. (2011). Hot topic: Lipophilic and amphiphilic interactions in glycoprotein 41: targets for therapy [Editorial]. Current Topics in Medicinal Chemistry, 11(24), 2945-2946. This material can be found here.

  • Gochin, M. (2012). A suite of modular fluorescence assays interrogate the human immunodeficiency virus Glycoprotein-41 coiled coil and assist in determining binding mechanism of low molecular weight fusion inhibitors. Assay and Drug Development Technologies, 10(5), 407-416. doi:10.1089/adt.2012.464

  • Gochin, M., & Cai, L. (2009). The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket. Journal of Medicinal Chemistry, 52(14), 4338-4344. doi: 10.1021/jm900190q This material can be found here.

  • Gochin, M., & Zhou, G. (2011). Amphipathic properties of HIV-1 gp41 fusion inhibitors. Current Topics in Medicinal Chemistry, 11(24), 3022-3032. This material can be found here.

  • Gochin, M., & Zhou, G. (2011). U.S. Patent No. 8,455,516. Washington, DC: U.S. Patent and Trademark Office.

  • Gochin, M., Whitby, L. R., Phillips, A. H., & Boger, D. L. (2013). NMR-assisted computational studies of peptidomimetic inhibitors bound in the hydrophobic pocket of HIV-1 glycoprotein 41. Journal of Computer-Aided Molecular Design, 27(7), 569-582.  doi:10.1007/s10822-013-9662-6

  • Gochin, M., Zhou, G., & Phillips, A. H. (2011). Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket. ACS Chemical Biology, 6(3), 267-274. This material can be found here.

  • Goff, D. C., McEvoy, J. P., Citrome, L., Mech, A. W., Bustillo, J. R., Gil, R., . . . Macklin, E. A. (2013). High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: The ZEBRAS study. Journal of Clinical Psychopharmacology, 33(4), 485-490. doi:10.1097/JCP.0b013e3182977308

  • Gokaldas, R., Singh, M., & Fekete, R. (2014). Who is your neurologist?: Measuring the efficacy of a resident run continuity clinic. Neurology, 82(10 Suppl.), P4.277.

  • Gokaldas, R., Singh, M., Lal, S., Benenstein, R. J., & Sahni, R. (2015). Carotid stenosis: From diagnosis to management, where do we stand?  Current Aherosclerosis Reports, 17(2), [Article 480]. doi:10.1007/s11883-014-0480-7

  • Gold, I. (1989). The heat wave. Aethlon: The Journal of Sport Literature, 7(1), 107-111.

  • Gold, I. (1991). Scapegoats. Midstream, 37(8), 34-36.

  • Gold, I. (1992). The Vizoosa of Flatbush. Midstream, 38(5), 40-42.

  • Gold, I. (1995). Folklaw. Kerem, 4.

  • Gold, I. (1995). Pests. The Madison Review, 15(2), 42-50.

  • Gold, I. (1995, Spring/Summer). Dreamday. Pennsylvania English, 19(2), 38-47.

  • Gold, I. (1996). A doll's life. Mark: A Literary Journal, 12, 50-56.

  • Gold, I. (1996, January). Zip city. City Primeval, 1(2), 9-18.

  • Gold, I. (1997, Autumn). Defenseless. The Rockford Review, 16(3), 11-12.

  • Gold, I. (1997). Chaya. New Delta Review, 14(2), 5-23.

  • Gold, I. (1997). Looking for Shem. Sounding East, 19(1), 51-60.

  • Gold, I. (1998). Bernstein. Whiskey Island, 21(2).

  • Gold, I. (1998). Frumkin's choice. Midstream, 44(5), 30-33.

  • Gold, I. (1998). Himmelman connected-1984. Mobius: Journal for Social Change, 9(3).

  • Gold, I. (1998). Sacred crackers. Image: A Journal of Religion and Literature, 20, 7-13.

First Prev 92 93 94 95 96 97 98 99 100 101 Next Last